Literature DB >> 20479333

Menstrual cycle affects renal-adrenal and hemodynamic responses during prolonged standing in the postural orthostatic tachycardia syndrome.

Qi Fu1, Tiffany B VanGundy, Shigeki Shibata, Richard J Auchus, Gordon H Williams, Benjamin D Levine.   

Abstract

Approximately 500,000 American premenopausal women have the postural orthostatic tachycardia syndrome (POTS). We tested the hypothesis that in POTS women during orthostasis, activation of the renin-angiotensin-aldosterone system is greater, leading to better compensated hemodynamics in the midluteal phase (MLP) than in the early follicular phase of the menstrual cycle. Ten POTS women and 11 healthy women (controls) consumed a constant diet 3 days before testing. Hemodynamics and renal-adrenal hormones were measured while supine and during 2-hour standing. We found that blood pressure was similar, heart rate and total peripheral resistance were greater, and cardiac output and stroke volume were lower in POTS subjects than in controls during 2-hour standing. In controls, hemodynamic parameters were indistinguishable between menstrual phases. In POTS subjects, cardiac output and stroke volume were lower and total peripheral resistance was greater in the early follicular phase than MLP after 30 minutes of standing; however, blood pressure and heart rate were similar between phases. Plasma renin activity (9+/-6 [SD] versus 13+/-9 ng/mL per hour; P=0.04) and aldosterone (43+/-22 versus 55+/-25 ng/dL; P=0.02) were lower in the early follicular phase than MLP in POTS subjects after 2 hours of standing. Catecholamine responses were similar between phases. The percentage rate of subjects having presyncope was greater in the early follicular phase than MLP for both groups (chi(2) P<0.01). These results suggest that the menstrual cycle modulates the renin-angiotensin-aldosterone system and affects hemodynamics during orthostasis in POTS. The high estrogen and progesterone in the MLP are associated with greater increases in renal-adrenal hormones and presumably more volume retention, which improve late-standing tolerance in these patients.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20479333      PMCID: PMC2894615          DOI: 10.1161/HYPERTENSIONAHA.110.151787

Source DB:  PubMed          Journal:  Hypertension        ISSN: 0194-911X            Impact factor:   10.190


  40 in total

1.  Hypovolemia in syncope and orthostatic intolerance role of the renin-angiotensin system.

Authors:  G Jacob; D Robertson; R Mosqueda-Garcia; A C Ertl; R M Robertson; I Biaggioni
Journal:  Am J Med       Date:  1997-08       Impact factor: 4.965

2.  Left ventricular pressure-volume and Frank-Starling relations in endurance athletes. Implications for orthostatic tolerance and exercise performance.

Authors:  B D Levine; L D Lane; J C Buckey; D B Friedman; C G Blomqvist
Journal:  Circulation       Date:  1991-09       Impact factor: 29.690

3.  Induction of calcium-dependent nitric oxide synthases by sex hormones.

Authors:  C P Weiner; I Lizasoain; S A Baylis; R G Knowles; I G Charles; S Moncada
Journal:  Proc Natl Acad Sci U S A       Date:  1994-05-24       Impact factor: 11.205

4.  Determination of hemoglobin mass and blood volume with CO: evaluation and application of a method.

Authors:  C M Burge; S L Skinner
Journal:  J Appl Physiol (1985)       Date:  1995-08

5.  Systemic and renal hemodynamic changes in the luteal phase of the menstrual cycle mimic early pregnancy.

Authors:  A B Chapman; S Zamudio; W Woodmansee; A Merouani; F Osorio; A Johnson; L G Moore; T Dahms; C Coffin; W T Abraham; R W Schrier
Journal:  Am J Physiol       Date:  1997-11

6.  Effects of estrogen replacement therapy on the renin-angiotensin system in postmenopausal women.

Authors:  H Schunkert; A H Danser; H W Hense; F H Derkx; S Kürzinger; G A Riegger
Journal:  Circulation       Date:  1997-01-07       Impact factor: 29.690

7.  Nitric oxide-mediated vasodilation in human pregnancy.

Authors:  D J Williams; P J Vallance; G H Neild; J A Spencer; F J Imms
Journal:  Am J Physiol       Date:  1997-02

8.  Abnormal norepinephrine and aldosterone responses to upright posture in nonmodulating hypertension.

Authors:  P R Conlin; L M Braley; A I Menachery; N K Hollenberg; G H Williams
Journal:  J Clin Endocrinol Metab       Date:  1992-10       Impact factor: 5.958

9.  Estradiol- and progesterone-related increases in the renin-aldosterone system: studies during ovarian stimulation and early pregnancy.

Authors:  J E Sealey; J Itskovitz-Eldor; S Rubattu; G D James; P August; I Thaler; J Levron; J H Laragh
Journal:  J Clin Endocrinol Metab       Date:  1994-07       Impact factor: 5.958

Review 10.  Postural tachycardia syndrome (POTS).

Authors:  P A Low; T L Opfer-Gehrking; S C Textor; E E Benarroch; W K Shen; R Schondorf; G A Suarez; T A Rummans
Journal:  Neurology       Date:  1995-04       Impact factor: 9.910

View more
  27 in total

1.  Anatomical, physiological and metabolic changes with gestational age during normal pregnancy: a database for parameters required in physiologically based pharmacokinetic modelling.

Authors:  Khaled Abduljalil; Penny Furness; Trevor N Johnson; Amin Rostami-Hodjegan; Hora Soltani
Journal:  Clin Pharmacokinet       Date:  2012-06-01       Impact factor: 6.447

2.  Gynecologic disorders and menstrual cycle lightheadedness in postural tachycardia syndrome.

Authors:  Kiffany J Peggs; Hovan Nguyen; Diba Enayat; Nancy R Keller; Ayman Al-Hendy; Satish R Raj
Journal:  Int J Gynaecol Obstet       Date:  2012-06-20       Impact factor: 3.561

3.  Short-term exercise training improves the cardiovascular response to exercise in the postural orthostatic tachycardia syndrome.

Authors:  Shigeki Shibata; Qi Fu; Tiffany B Bivens; Jeffrey L Hastings; Wade Wang; Benjamin D Levine
Journal:  J Physiol       Date:  2012-05-28       Impact factor: 5.182

4.  Altered systemic hemodynamic and baroreflex response to angiotensin II in postural tachycardia syndrome.

Authors:  Hossam I Mustafa; Satish R Raj; André Diedrich; Bonnie K Black; Sachin Y Paranjape; William D Dupont; Gordon H Williams; Italo Biaggioni; David Robertson
Journal:  Circ Arrhythm Electrophysiol       Date:  2012-01-13

Review 5.  Postural tachycardia syndrome - Diagnosis, physiology, and prognosis.

Authors:  Amy C Arnold; Jessica Ng; Satish R Raj
Journal:  Auton Neurosci       Date:  2018-02-28       Impact factor: 3.145

6.  Cutaneous constitutive nitric oxide synthase activation in postural tachycardia syndrome with splanchnic hyperemia.

Authors:  Julian M Stewart; Abhinav Nafday; Anthony J Ocon; Courtney Terilli; Marvin S Medow
Journal:  Am J Physiol Heart Circ Physiol       Date:  2011-06-03       Impact factor: 4.733

7.  Ascorbate improves circulation in postural tachycardia syndrome.

Authors:  Julian M Stewart; Anthony J Ocon; Marvin S Medow
Journal:  Am J Physiol Heart Circ Physiol       Date:  2011-05-27       Impact factor: 4.733

8.  Exercise training versus propranolol in the treatment of the postural orthostatic tachycardia syndrome.

Authors:  Qi Fu; Tiffany B Vangundy; Shigeki Shibata; Richard J Auchus; Gordon H Williams; Benjamin D Levine
Journal:  Hypertension       Date:  2011-06-20       Impact factor: 10.190

9.  Effects of Menstrual Cycle Phase on Fluid Regulation during Walking Exercise.

Authors:  Yuka Nose; Kana Fujita; Takuma Wada; Kazuki Nishimura; Masayuki Hakoda
Journal:  J Sports Sci Med       Date:  2020-08-13       Impact factor: 2.988

10.  Ovarian cycle and sympathoexcitation in premenopausal women.

Authors:  Jason R Carter; Qi Fu; Christopher T Minson; Michael J Joyner
Journal:  Hypertension       Date:  2012-11-19       Impact factor: 10.190

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.